Literature DB >> 8093914

Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis.

Q Xu1, J Willeit, M Marosi, R Kleindienst, F Oberhollenzer, S Kiechl, T Stulnig, G Luef, G Wick.   

Abstract

Arteriosclerotic lesions can be induced in normocholesterolaemic rabbits by immunisation with heat-shock protein (hsp) 65, a stress protein expressed in high concentrations in human atherosclerotic lesions. If an immune reaction to hsp65 also plays a part in human atherogenesis, it should be possible to detect anti-hsp65 antibodies in patients with atherosclerotic lesions. To study the possible relation between immune reaction to hsp65 and atherosclerosis, 867 normal inhabitants of South Tyrol, aged 40-79 years, were selected randomly for determination of serum antibodies against hsp65, simultaneous sonographic assessment of carotid atherosclerotic lesions, and evaluation of established risk factors--ie, blood cholesterol, hypertension, smoking, diabetes mellitus, and obesity. Autoantibodies to nuclear antigens, thyroid antigens, and rheumatoid factors were also measured. Serum anti-hsp65 antibodies were significantly (p < 0.05) increased in subjects aged 60-79 years with carotid atherosclerosis compared with those without lesions, and increased antibody concentration was independent of age, sex, and other established risk factors. On the other hand, the incidence and titres of autoantibodies did not correlate with carotid atherosclerotic lesions. Our data provide the first evidence of a strong correlation between anti-hsp65 antibodies and carotid atherosclerosis, suggesting that hsp65 might be involved in the pathogenesis of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093914     DOI: 10.1016/0140-6736(93)92613-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  99 in total

Review 1.  [Angiology update].

Authors:  C Ranke; H J Trappe
Journal:  Med Klin (Munich)       Date:  1999-05-15

2.  Strong correlation between Helicobacter pylori seropositivity and Chlamydia pneumoniae IgG concentrations.

Authors:  J Danesh; Y K Wong; M Ward; P Hawtin; M Murphy; J Muir
Journal:  J Epidemiol Community Health       Date:  1998-12       Impact factor: 3.710

3.  Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study.

Authors:  D P Strachan; D Carrington; M A Mendall; L Ballam; J Morris; B K Butland; P M Sweetnam; P C Elwood
Journal:  BMJ       Date:  1999-04-17

4.  Association of plasma antibodies against the inducible Hsp70 with hypertension and harsh working conditions.

Authors:  T Wu; J Ma; S Chen; Y Sun; C Xiao; Y Gao; R Wang; J Poudrier; M Dargis; R W Currie; R M Tanguay
Journal:  Cell Stress Chaperones       Date:  2001-10       Impact factor: 3.667

Review 5.  Role of infectious and immune factors in coronary and cerebrovascular arteriosclerosis.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

6.  T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens.

Authors:  A J Curry; I Portig; J C Goodall; P J Kirkpatrick; J S Gaston
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 7.  Systemic diseases caused by oral infection.

Authors:  X Li; K M Kolltveit; L Tronstad; I Olsen
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 8.  Molecular chaperones and heat shock proteins in atherosclerosis.

Authors:  Qingbo Xu; Bernhard Metzler; Marjan Jahangiri; Kaushik Mandal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

9.  Atypical mycobacteria in a superficial femoral artery occlusion.

Authors:  C Determann; A T Hill; H Monaghan; S C A Fraser
Journal:  BMJ Case Rep       Date:  2011-03-10

Review 10.  Immunological aspects of atherosclerosis.

Authors:  S Garrido-Urbani; M Meguenani; F Montecucco; B A Imhof
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.